tiprankstipranks
Biosergen AB (DE:8N1)
:8N1
Germany Market
Holding DE:8N1?
Track your performance easily

Biosergen AB (8N1) Financial Statements

0 Followers

Biosergen AB Financial Overview

Biosergen AB's market cap is currently ―. The company's EPS TTM is €-0.024; its P/E ratio is ―; Biosergen AB is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is €0.00. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Sep 21Jun 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 2.71M$ 0.00
Gross Profit$ 0.00$ -122.00K$ 0.00$ 2.53M-
EBIT$ -14.52M$ -7.96M$ -5.02M$ -6.58M$ -12.54M
EBITDA$ -14.52M$ -7.96M$ -5.02M$ -6.58M$ -12.54M
Net Income Common Stockholders$ -14.50M$ -7.96M$ -5.01M$ -6.73M$ -12.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.46M$ 5.72M$ 9.70M$ 36.84M$ 41.28M
Total Assets$ 12.93M$ 13.62M$ 18.46M$ 40.24M$ 43.21M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 20.70M$ 7.06M$ 3.56M$ 10.33M$ 6.93M
Stockholders Equity$ -7.77M$ 6.56M$ 14.90M$ 29.91M$ 36.28M
Cash Flow-
Free Cash Flow$ 3.74M$ -3.98M$ -11.96M$ -4.08M$ -12.70M
Operating Cash Flow$ 3.74M$ -3.98M$ -11.96M$ -4.08M$ -12.70M
Investing Cash Flow---$ 0.00$ 3.98M
Financing Cash Flow$ 0.00$ 0.00$ 0.00$ -363.00K$ 50.00M
Currency in USD

Biosergen AB Earnings and Revenue History

Biosergen AB Debt to Assets

Biosergen AB Cash Flow

Biosergen AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis